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Actin binding to WH2 domains regulates nuclear 
import of the multifunctional actin regulator JMY
J. Bradley Zuchero, Brittany Belin, and R. Dyche Mullins
Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158; Physiology 
Course, Marine Biological Laboratory, Woods Hole, MA 02543
ABSTRACT Junction-mediating and regulatory protein (JMY) is a regulator of both transcrip-
tion and actin filament assembly. In response to DNA damage, JMY accumulates in the nucle-
us and promotes p53-dependent apoptosis. JMY’s actin-regulatory activity relies on a cluster 
of three actin-binding Wiskott–Aldrich syndrome protein homology 2 (WH2) domains that 
nucleate filaments directly and also promote nucleation activity of the Arp2/3 complex. In 
addition to these activities, we find that the WH2 cluster overlaps an atypical, bipartite nucle-
ar localization sequence (NLS) and controls JMY’s subcellular localization. Actin monomers 
bound to the WH2 domains block binding of importins to the NLS and prevent nuclear import 
of JMY. Mutations that impair actin binding, or cellular perturbations that induce actin fila-
ment assembly and decrease the concentration of monomeric actin in the cytoplasm, cause 
JMY to accumulate in the nucleus. DNA damage induces both cytoplasmic actin polymeriza-
tion and nuclear import of JMY, and we find that damage-induced nuclear localization of JMY 
requires both the WH2/NLS region and importin β. On the basis of our results, we propose 
that actin assembly regulates nuclear import of JMY in response to DNA damage.
INTRODUCTION
Junction-mediating and regulatory protein (JMY) leads a double life 
in vertebrate cells. In the cytoplasm it promotes actin filament as-
sembly and contributes to cell migration (Zuchero et al., 2009), 
whereas in the nucleus it acts as a transcriptional coactivator and 
promotes programmed cell death in response to DNA damage 
(Shikama et al., 1999; Coutts et al., 2007). The connection between 
these distinct cellular functions has remained mysterious.
JMY’s effects on actin assembly require its C-terminal WWWCA 
region, composed of three, tandem actin monomer–binding se-
quences (Wiskott–Aldrich syndrome protein homology 2 [WH2] do-
mains) and an Arp2/3-binding central and acidic (CA) region. Similar 
to WH2-CA domains found in Wiskott–Aldrich syndrome protein–
family proteins, this region of JMY can promote actin nucleation by 
the Arp2/3 complex (Welch and Mullins, 2002). In addition, the clus-
ter of WH2 domains can also nucleate actin filaments by itself, using 
a mechanism remarkably similar to that of the spire-family proteins 
(Quinlan et al., 2005). In slow-moving cells (e.g., fibroblasts) endog-
enous JMY occurs in both the nucleus and the cytoplasm, but in 
highly motile cells (e.g., neutrophils), it is predominantly cytoplasmic 
and specifically enriched at the leading edge. Both the rate of cell 
migration and the cytoplasmic concentration of filamentous actin 
increase when JMY is overexpressed and decrease when JMY ex-
pression is knocked down by RNA interference (RNAi; Zuchero et al., 
2009). The JMY-dependent increase in cell motility requires its 
Arp2/3-binding region and is not observed when JMY localization is 
restricted to the nucleus (Coutts et al., 2009; Zuchero et al., 2009) 
either by DNA damage or by fusion to a strong nuclear localization 
sequence (NLS). In nerve cells, JMY appears to suppress neurite 
outgrowth, an activity that requires its intrinsic actin nucleation activ-
ity (Firat-Karalar et al., 2011). Of interest, actin assembly by the 
Arp2/3 complex also suppresses neurite outgrowth and axon migra-
tion in nerve cells (Strasser et al., 2004). Taken together, the data 
indicate that JMY regulates cell shape and motility, at least in part, 
by promoting actin assembly in the cytoplasm.
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2000; Kiuchi et al., 2011), latrunculin B (LatB) to depolymerize actin 
filaments and increase monomer concentration (Spector et al., 1983; 
Lyubimova et al., 1997), or leptomycin B (LMB) to inhibit exportin1/
Crm1–dependent nuclear export (Wolff et al., 1997). We then frac-
tionated cells into cytoplasmic and nuclear pools and assessed pro-
tein localization by immunoblotting (Supplemental Figure S1A). 
Probes against cytoplasmic (HSP70) and nuclear (lamin B1) markers 
demonstrate the efficiency of fractionation (Figure 1B and Supple-
mental Figure S1A). When suitable antibodies were not available, 
we expressed candidates as green fluorescent protein (GFP) fusions 
(including MAL and Phactr1) and analyzed localization by fluores-
cence microscopy (Supplemental Figure S1B).
Actin regulates the subcellular localization of JMY
Of the 14 proteins we tested, only three exhibit changes in localiza-
tion as a function of actin assembly/disassembly: JMY, MAL (also 
known as MRTF-A and MKL1), and Phactr1. Consistent with previous 
reports (Vartiainen et al., 2007), MAL accumulates in the nucleus in 
response to jasp and LMB and in the cytoplasm in response to LatB 
(Supplemental Figure S1B, top). Phactr1, another RPEL motif–con-
taining protein (Sagara et al., 2009), accumulates in the nucleus in 
response to jasp (Supplemental Figure S1B, bottom, and c) and co-
localizes with actin-based structures in the cytoplasm (Supplemental 
Figure S1D). It is striking that both endogenous and GFP-tagged 
JMY also accumulate in the nucleus in response to jasp (fold increase 
in nuclear JMY, 2.45 ± 0.62 SEM; in GFP-JMY, 2.68 ± 0.14; Figure 1, 
B and C, and Supplemental Figure S1A). We confirmed these results 
by fluorescence microscopy of GFP-JMY in live cells (Figure 1, D and 
E). GFP-JMY was enriched in the nucleus of only 2.2 ± 1.1% of mock-
treated cells (78.6 ± 5.4% predominantly cytoplasmic), and treatment 
with jasp increased this localization by almost 10-fold (19.0 ± 2.4% 
nuclear; 31.3 ± 2.7% cytoplasmic). In contrast to MAL, however, we 
observed no change in JMY localization in response to LMB or LatB 
(Supplemental Figure S1A; see also later discussion of Figure 3).
Does the actin-dependent localization of JMY depend on its 
ability to bind actin monomers? To test this, we made point muta-
tions in JMY WH2 domains (where [A*B*C*] refers to mutations 
made in WH2-a, -b, and -c) previously shown to compromise actin 
binding (Quinlan et al., 2005; Kelly et al., 2006). We validated these 
mutations in vitro using pyrene actin assembly assays (Supplemental 
Figure S2, A and B). Consistent with the effects of jasp, compromis-
ing the ability of all three WH2 domains to bind actin (GFP-
JMY[A*B*C*]) causes JMY to become completely nuclear (Figure 
1F). Putative NLS-2 overlaps both the C-terminal LRKT motif of 
WH2-a and the linker connecting it to WH2-b (Supplemental Figure 
S2C), and so we tested the effect of mutating only the first two WH2 
domains. Similar to the [A*B*C*] triple mutant, the double mutant 
GFP-JMY[A*B*] also accumulates in the nucleus despite being able 
to bind actin on WH2-c (Figure 1F and Supplemental Figure S2, A 
and B). These results suggest that actin monomers bound to WH2-a 
and -b block JMY nuclear import by masking NLS-2.
To understand the function and regulation of JMY’s putative NLS 
regions, we tested their function by fusing them to GFP. The nuclear 
pore complex has a mesh size of ∼2.6 nm and, in the absence of a 
functional NLS, GFP (Stokes radius, 2.4 nm) equilibrates slowly be-
tween the nucleus and cytoplasm (Mohr et al., 2009). Accordingly, 
we find GFP distributed equally between cytoplasm and nucleus 
(predominantly nuclear in 4.9% of cells). Its localization shifts to the 
nucleus when fused to either a control NLS from the SV40 large T 
antigen (98.5% nuclear), JMY NLS-1 (95.6% nuclear), or JMY NLS-2 
(83.2% nuclear; Figure 1, G and H). This demonstrates that both 
JMY NLS-1 and -2 are functional.
In response to DNA damage, JMY accumulates in the nucleus, 
where it enhances transcription by the tumor suppressor p53 and 
promotes apoptosis (Shikama et al., 1999; Coutts et al., 2007). Three 
additional proteins are known to modulate JMY’s nuclear function: 
the acetyltransferase p300, an adaptor protein called Strap, and the 
ubiquitin ligase Mdm2. In the nucleus, JMY forms a complex with 
p300 and Strap that is believed to acetylate p53 and increase its 
proapoptotic transcriptional activity. Mdm2 can oppose this activity 
by promoting degradation of both JMY and p53. Given growing 
evidence that actin has important functions in the nucleus, including 
regulation of transcription, it is tempting to speculate that JMY 
might make actin filaments in the nucleus. There is, however, no evi-
dence to support this idea.
To understand the connection between its nuclear and cytoplas-
mic functions, we investigated the mechanism by which JMY trans-
locates from the cytoplasm into the nucleus. Surprisingly, we find 
that decreases in the cytoplasmic concentration of monomeric actin 
drive translocation of JMY into the nucleus and that actin-depen-
dent translocation is controlled by the cluster of WH2 domains. We 
identified a bipartite nuclear localization sequence that partially 
overlaps the WH2 cluster and found that WH2 mutations that pre-
vent actin binding are sufficient to drive JMY into the nucleus. In 
vitro, monomeric actin bound to the WH2 domains blocks access of 
the importin α/β (Impα/β) complex to JMY’s NLS. This mechanism of 
regulation is remarkably similar to that of the myocardin-related 
transcription factor (MRTF) proteins, whose nuclear localization is 
also actin dependent but which use an unrelated actin-binding se-
quence called a RPEL domain. The lack of sequence similarity and 
the evolutionary history of JMY argue strongly that the similarities in 
MRTF and JMY regulation represent a case of convergent evolution. 
Of interest, DNA damage–induced nuclear accumulation of JMY 
absolutely requires the actin-sensitive nuclear localization sequence 
embedded in the WWWCA domain. We find that DNA damage suf-
ficient to produce nuclear accumulation of JMY also induces incor-
poration of monomeric actin into cytoplasmic filaments incapable of 
binding JMY. Our work argues strongly that nuclear translocation of 
JMY in response to DNA damage is an actin-dependent process.
RESULTS
Identification of proteins with both a putative actin-binding 
domain and NLS
To identify factors that might link actin dynamics to nuclear events, 
we searched the human genome for coding sequences containing 
one or more potential actin-binding domains and at least one pre-
dicted nuclear localization sequence (Nair et al., 2003). We tested 
both actin monomer-binding (WH2 and RPEL) and filament-binding 
(calponin homology, formin homology 2, ILWEQ, and ezrin/radixin/
moesin) sequences and identified 28 proteins that met our criteria 
(Supplemental Table S1). Of interest, in 14 of these proteins the 
predicted actin-binding domain (ABD) overlaps or is adjacent to the 
NLS (Figure 1A). This motif occurs in several well-known actin mono-
mer–binding proteins (JMY, MRTF proteins, Phactr1-4, Scar2/
WAVE2), formin-family members (Daam1-2, Diaph1, Fhod3), canon-
ical adhesion proteins (ezrin, radixin, moesin, talin), and others, in-
cluding SYNE/nesprin proteins, dystonin, neuron navigator, and 
huntingtin interacting protein 1.
We used cell fractionation and fluorescence microscopy to test 
whether the proteins with overlapping ABD and NLS sequences 
shuttle between the cytoplasm and nucleus and whether their local-
ization depends on the state of the actin cytoskeleton. We treated 
cells with jasplakinolide (jasp) to polymerize actin and reduce the 
cytoplasmic concentration of actin monomers (Bubb et al., 1994, 
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FIguRE 1: Actin regulates the subcellular localization of JMY. (A) Proteins with overlap between putative NLS and 
ABDs. The table indicates Uniprot number (http://www.uniprot.org), type of ABD, cellular localization (Loc.), function, 
and a diagram showing position of the putative NLS relative to the ABD. References and full gene names are found in 
Supplemental Table S1. Asterisk indicates putative (uncharacterized) ABD. Bottom, domain structure of JMY, showing 
position of putative NLSs (NLS-1, amino acids 603–620; NLS-2, 867–882). WH2s are abbreviated Wa, Wb, and Wc. 
Other domains illustrated are as follows: NT, N-terminal; Pro, polyproline; C, Central; A, acidic (Zuchero et al., 2009). 
(B, C) Endogenous and GFP-JMY accumulate in the nucleus following polymerization of actin with 500 nM jasp for 
30 min. Following drug treatment, wild-type cells or cells stably expressing GFP-JMY were fractionated into cytoplasmic 
and nuclear pools (see Materials and Methods). Immunoblotting was performed to assess the localization of JMY, and 
fraction purity was determined by blotting with HSP70 (cytoplasmic marker) and lamin B1 (nuclear marker). 
(C) Quantification of immunoblots indicates that both endogenous and GFP-tagged JMY are ∼2.5 times more nuclear in 
jasp-treated cells relative to untreated cells. Error bars, SEM; n ≥ 3. (D, E) Analysis of GFP-JMY localization by 
microscopy. GFP-JMY accumulates in the nucleus in response to actin polymerization induced by jasplakinolide. JMY 
constructs were transiently expressed in HeLa cells for 16 h prior to treatment with jasp or DMSO (mock). 
(E) Quantification of ≥300 cells per condition, n ≥ 3, showing percentage of cells that were predominantly cytoplasmic 
(gray), equally distributed in cytoplasm and nucleus (C/N, white) or predominantly nuclear (black). *p < 0.05, 
***p < 0.005. (F) Actin-binding mutants GFP-JMY[A*B*] and GFP-JMY[A*B*C*] are completely nuclear. Cells were 
transfected and fractionated as in B. n = 2. (G, H) JMY NLS-1 and NLS-2 are functional NLS sequences. Tagging GFP 
with either a control NLS (SV40) or JMY NLS drives it into the nucleus. (G) Quantification of GFP localization in 
≥130 cells per condition, n = 2. All scale bars, 20 μm.
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the nucleus and cytoplasm, in most cells (only 21.4 ± 3.0% nuclear; 
Figure 2, A and F). It rapidly accumulates in the nucleus in response 
to actin polymerization by jasp, and its accumulation is more robust 
than that for full-length JMY (6.5 ± 0.2% cytoplasmic, 51.8 ± 5.1% 
nuclear in jasp-treated cells; Figure 2, B and F). Cellular fractionation 
confirms this observation (Figure 2D), and time-lapse microscopy 
demonstrates that GFP-PWWWCA accumulates in the nucleus after 
Actin-dependent localization of JMY is recapitulated 
by gFP-PWWWCA
We next asked whether the C-terminal (PWWWCA, where P stands 
for polyproline domain) region of JMY, which contains both the ac-
tin-binding WH2 domains and NLS-2, is sufficient for actin-depen-
dent nuclear accumulation. Similar to full-length GFP-JMY, GFP-
PWWWCA is largely cytoplasmic, or equally distributed between 
FIguRE 2: The C-terminus of JMY recapitulates actin-dependent localization. (A–C) Whereas GFP-PWWWCA is largely 
cytoplasmic (A), it accumulates in the nucleus following polymerization of actin with jasp (B) or when actin binding is 
blocked with WH2 point mutations (GFP-PWWWCA[A*B*C*]; C). Cells transiently transfected with GFP constructs were 
treated for 30 min with jasp as marked, then fixed and imaged. (D) Cellular fractionations as in Figure 1B show 
accumulation of GFP-PWWWCA in the nucleus following jasp treatment. (E) Time-lapse microscopy of GFP-PWWWCA 
following addition of 500 nM jasp. All scale bars, 20 μm. (F) Top, diagram showing C-terminal JMY fragments. Bottom, 
quantification of microscopy in (a–h); >150 cells per condition, n = 3. **p < 0.01; ***p < 0.005. Conditions are compared 
with GFP-PWWWCA alone, except where indicated with colored brackets. C/N, equally distributed in cytoplasm and 
nucleus. (G, H) Impβ is required for nuclear localization of the GFP-PWWWCA[A*B*C*] mutant. (G) Immunoblot showing 
that Impβ expression was knocked down by RNAi with an Impβ-specific siRNA but not control siRNA (see also 
Supplemental Figure S5, a). (H) RNAi of Impβ, but not control siRNA, causes GFP-PWWWCA[A*B*C*] localization to 
shift from exclusively nuclear to equally distributed between the nucleus and cytoplasm. This demonstrates that its 
normal nuclear localization is dependent on Impβ.
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plained by polymerization inducing either 1) 
an increase in the rate of nuclear import or 
2) a decrease in the rate of nuclear export. 
For decreased export to promote nuclear 
accumulation, JMY would have to normally 
shuttle between the cytoplasm and nucleus. 
Arguing against the second model, we 
found that neither endogenous nor GFP-
JMY accumulates in the nucleus after export 
is blocked with LMB for 30 min (GFP-JMY 
from 1.2 ± 0.7% nuclear to 1.3 ± 0.7% nu-
clear; Figure 3, A and B). Immunoblots of 
fractionated cells reveal no nuclear accumu-
lation of GFP-JMY even when cells are 
grown overnight with LMB (Figure 3C). In 
contrast, MAL accumulates in the nucleus 
immediately after blocking of nuclear export 
with LMB (Vartiainen et al., 2007; Figure 3, A 
and B). This suggests that JMY does not 
normally shuttle between the cytoplasm 
and nucleus. JMY has no putative nuclear 
export signal (la Cour et al., 2004), but it re-
mains possible that its export from the nu-
cleus is independent of Crm-1 but depen-
dent on actin. Depolymerizing actin with 
LatB induces cytoplasmic localization of 
MAL or the MAL RPEL cluster but has no sig-
nificant effect on full-length GFP-JMY or 
GFP-PWWWCA (Figure 3D). This is also true 
in DNA-damaged cells, in which basal GFP-
JMY localization is more nuclear (Supple-
mental Figure S3B). Thus, export of JMY is 
not regulated by actin monomers.
Actin and importins compete 
for binding to JMY
The spatial overlap between the importin-
binding NLS and actin-binding WH2 do-
mains (Supplemental Figure S2C) suggests 
a model for how actin regulates JMY nuclear 
import. Do actin monomers inhibit import of JMY by directly com-
peting with the binding of importins? We developed a glutathione 
S-transferase (GST) pulldown assay that allows us to simultaneously 
detect binding of actin monomers, Impα, and Impβ to GST-tagged 
JMY WWWCA or GST alone. Actin and importins bind to GST-JMY, 
whereas very little binds nonspecifically to GST alone (Figure 4, A 
and B). Titrating the actin monomer concentration shows that actin 
effectively competes Impα/β off of GST-JMY (Figure 4, C and D). 
Competition is dose dependent and saturates at ∼10 μM, approxi-
mately the same concentration at which actin binding saturates. 
Using depletion of Impα/β from the supernatant as an indirect read-
out of binding affinity, we confirmed that actin competes with bind-
ing of Impα/β to JMY (Supplemental Figure S3G). Competition is 
greatly attenuated when the affinity for actin binding to WH2-a and 
WH2-b is weakened using the same mutations as in Figure 1 (see 
Supplemental Figure S3, C and D).
Impα is normally autoinhibited but becomes able to bind an 
NLS following binding of Impβ (Fanara et al., 2000; Catimel et al., 
2001). Accordingly, Impα does not bind to GST-JMY in the absence 
of Impβ, demonstrating that the binding we see in the presence of 
the Impα/β complex is specific (Figure 4, A and B). Impβ, however, 
binds directly to GST-JMY in the absence of Impα. Although NLSs 
just 10–15 min of treatment (Figure 2E). WH2 point mutations that 
block actin binding (GFP-PWWWCA[A*B*C*]) cause JMY localiza-
tion to become almost entirely nuclear (85.1% nuclear; Figure 2, C 
and F). Of interest, although PWWW (lacking the CA domain) be-
haves similarly to PWWWCA (32.4 ± 3.0% nuclear), removing the 
polyproline domain (WWW) decreases the fraction of cells with nu-
clear JMY to 74.8 ± 0.5% (Figure 2F and Supplemental Figure S3A; 
see Discussion).
Is the nuclear localization of GFP-PWWWCA[A*B*C*] dependent 
on the classical nuclear import machinery of Impα and Impβ? Hu-
mans have several Impα paralogues but only one Impβ (Quensel 
et al., 2004), so to test this we knocked down Impβ expression by 
RNAi (Figure 2G; see also Supplemental Figure S5A). In cells treated 
with Impβ small interfering RNA (siRNA), but not control siRNA, 
GFP-PWWWCA[A*B*C*] loses its strict nuclear localization (Figure 
2, F and H). This suggests that nuclear accumulation of JMY is due 
to regulated import and not diffusion through the nuclear pore.
Nuclear localization of JMY is not regulated by export
In addition to controlling the rate of nuclear import of JMY, does 
actin also control the rate of export? Our observation that actin po-
lymerization causes JMY to accumulate in the nucleus can be ex-
FIguRE 3: Nuclear accumulation of JMY is not regulated by export. (A–C). GFP-JMY does not 
accumulate in the nucleus following inhibition of Crm-1–dependent nuclear export by LMB. 
(A) Cells transiently transfected with GFP-JMY or MAL-GFP (control) were imaged immediately 
and 30 min after adding LMB. GFP-JMY remains in the cytoplasm, whereas MAL-GFP rapidly 
accumulates in the nucleus. Scale bars, 20 μm. (B) Transiently transfected cells were treated with 
LMB as marked for 30 min, fixed, and imaged. LMB does not induce nuclear accumulation of 
JMY. In contrast, MAL-GFP is significantly more nuclear following LMB treatment. *p <0.05. 
More than100 cells per condition, n = 2. (C) Cellular fractionations show that JMY does not 
accumulate in the nucleus of cells grown overnight in the presence of LMB. (D) LatB drives 
export of RPEL-GFP but not of GFP-JMY or GFP-PWWWCA. *p <0.05; >100 cells per condition, 
n = 3 for all conditions, except GFP-PWWWCA + Lat and RPEL-GFP + Lat, n = 2. C/N, equally 
distributed in cytoplasm and nucleus.
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demonstrate that actin regulates JMY and 
MAL localization by the same mechanism: 
competing with importins for direct binding.
Importins and actin binding control 
DNA damage–induced nuclear 
accumulation of JMY
The established nuclear role of JMY is as a 
transcriptional coactivator of p53. DNA dam-
age causes both increase in JMY expression 
and accumulation of JMY in the nucleus, 
where it potentiates p53-dependent tran-
scription of proapoptotic genes (Shikama 
et al., 1999; Coutts et al., 2007). Does DNA 
damage trigger JMY localization to the nu-
cleus by the same mechanism as the actin 
polymerization-induced accumulation that 
we have described? Recent work from sev-
eral groups revealed that DNA damage in-
duces polymerization of cytoplasmic actin 
(Levee et al., 1996; Guerra et al., 2008; Croft 
et al., 2011; Ishimoto et al., 2011). These 
studies were conducted using multiple cell 
types and genotoxic agents, suggesting that 
actin polymerization is a general response to 
DNA damage. On the basis of these results, 
we tested whether UV-induced DNA dam-
age also promotes actin filament assembly. It 
is striking that we found that following DNA 
damage, actin polymer concentrations (mea-
sured by average cellular intensity of Alexa 
568–phalloidin) nearly double (568–phalloi-
din intensity: untreated, 1.0 ± 0.04 arbitrary 
fluorescence units; 12 h post-UV, 1.4 ± 0.2; 
24 h post-UV, 1.8 ± 0.1; Figure 5, A and B). Of 
importance, the UV treatment conditions that 
induce actin polymerization are identical to 
those that cause JMY nuclear accumulation.
JMY accumulates in the nucleus following 
DNA damage caused by multiple agents, including UV irradiation, 
etoposide, and neocarzinostatin (Figure 5, C and D, and Supplemen-
tal Figure S5; see also Supplemental Figure S3B). Following UV treat-
ment, GFP-JMY is predominantly nuclear in 54.6 ± 3.2% of cells, 
compared with 4.1 ± 1.4% of control cells. As expected, DNA dam-
age–induced nuclear import of JMY requires Impβ (following UV 
treatment JMY is predominantly nuclear in only 2.6 ± 1.6% of Impβ 
RNAi cells; Supplemental Figure S5, A–C). In contrast to full-length 
JMY, the truncation mutant ΔWWWCA does not accumulate in the 
nucleus in response to UV (percentage nuclear: pre-UV, 0.0 ± 0%; 
post-UV, 0.4 ± 0.4%; Figure 5, C and D) or etoposide (Supplemental 
Figure S5, D and E), demonstrating that this region, which contains 
NLS-2 (but not NLS-1), is required for DNA damage–induced nuclear 
import. The truncation mutant ΔCA, which lacks its Arp2/3-binding 
site but still contains NLS-2 and the WH2 domains, is indistinguish-
able from full-length JMY (Supplemental Figure S5D). Together, these 
results suggest that DNA damage causes JMY nuclear accumulation 
by driving actin polymerization, which reduces actin monomers 
bound to JMY and allows for importin-dependent nuclear import.
DISCUSSION
Previous work demonstrated that, in response to DNA damage, 
JMY accumulates in the nucleus and promotes p53-mediated 
are typically bound directly by Impα, some arginine-rich NLSs (like 
JMY NLS-2) also interact directly with Impβ (Palmeri and Malim, 
1999; Fontes et al., 2003).
Because actin and importins compete for binding to JMY and 
Impβ is sufficient to bind JMY, does Impβ block actin nucleation by 
JMY? We find that Impβ markedly decreases the rate of JMY-cata-
lyzed actin polymerization in vitro but has no effect on actin poly-
merization in the absence of JMY or on Arp2/3 activation by a 
C-terminal fragment of JMY (WCA) lacking NLS-2 (Supplemental 
Figure S3, E and F, and data not shown). Nucleation activity is not 
completely blocked, and the decrease in activity saturates at ap-
proximately the same activity as a JMY fragment lacking WH2-a 
(JMY WWCA), suggesting that, at least in vitro, importins are only 
able to block actin from binding to WH2-a.
On the basis of these results, we tested whether this competition 
mechanism is conserved between JMY and MAL. MAL binds actin 
monomers using a cluster of three RPEL motifs (Miralles et al., 2003; 
Guettler et al., 2008) that overlap with a functional NLS (Vartiainen 
et al., 2007). Like JMY, MAL accumulates in the nucleus when actin 
polymerizes. We find that purified actin and importins also compete 
for binding to the MAL RPEL cluster (Supplemental Figure S5, A–E), 
consistent with recent findings (Pawłowski et al., 2010). Unlike JMY, 
MAL does not nucleate actin (Supplemental Figure S4F). These results 
FIguRE 4: Importins and actin compete for binding to JMY. (A, B) GST pulldown showing that 
actin, Impα, and Impβ bind to JMY GST-WWWCA. Following incubation of purified proteins with 
GST-WWWCA glutathione–Sepharose beads, the supernatant (S) was removed, the beads were 
washed, and bound proteins (P) were eluted. Actin (5% Alexa 488 labeled) was kept monomeric 
by the inclusion of 2× molar excess of LatB. Impβ binds even in the absence of Impα, but Impα 
binds only in the presence of Impβ, consistent with it being autoinhibited (Fanara et al., 2000). 
GST alone is used to show background, which is largely nonspecific binding to the resin. 
SDS–PAGE gels were first scanned for Alexa 488 actin and then stained with SYPRO Red to 
visualize proteins (see also full gel scan in Supplemental Figure S4, f). (B) Bound proteins were 
quantified using ImageQuant software. (C, D) Actin competes with Impα/β for binding to JMY. 
GST-WWWCA beads were incubated with 2.5 μM Impα and Impβ and increasing concentrations 
of LatB-actin. By 10–15 μM actin, actin binding has saturated and bound importin levels have 
been reduced to the level of nonspecific binding. (D) Quantification of bound Impα and Impβ, 
showing the averages from three independent experiments. Inset, bound actin. Error bars, SEM.
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FIguRE 5: Importins and actin binding control DNA damage–induced nuclear accumulation of JMY. (A, B) Actin 
polymerizes in U2OS cells in response to DNA damage induced by UV irradiation (50 J/m2). Cells were treated with UV 
at staggered start times and fixed at the same time and then stained with Alexa 568–phalloidin (see Materials and 
Methods). (A) Untreated cells (top) and cells 24 h after UV treatment (bottom). Left, merged images of Alexa 
568–phalloidin and DAPI. Right, Alexa 568–phalloidin images are false colored to show intensity (ImageJ). Scale bars, 
5 μm. (B) Quantification of average cellular Alexa 568–phalloidin intensity in cells without and at several time points after 
UV treatment. n = 4 coverslips, on two separate days. (C, D) GFP-JMY, but not ΔWWWCA, accumulates in the nucleus in 
response to DNA damage induced by UV irradiation. Cells stably expressing GFP-JMY or GFP-JMYΔWWWCA (Zuchero 
et al., 2009) were imaged before and 20 h after UV treatment (50 J/m2). Scale bars, 10 μm. (D) Quantification of >240 
cells per condition, n = 3. C/N, equally distributed in cytoplasm and nucleus. *p <0.05, ***p <0.005. (E) Model of how 
actin regulates nuclear import of JMY. (i) In untreated cells, the polyproline domain feeds free actin monomers to JMY 
WH2 domains, which blocks binding of importins, keeping JMY in the cytoplasm. (ii) Following DNA damage or 
treatment with jasp, actin polymerizes. This decreases the concentration of free monomer and allows importins to bind 
JMY and import it into the nucleus. (iii) In the case of actin-binding mutants (e.g., GFP-JMY[A*B*]), importins can 
constitutively bind and import JMY into the nucleus. (iv) JMY lacking the polyproline domain may be unable to bind 
actin monomers, making this mutant equivalent to actin binding–deficient mutants.
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JMY, so it will be essential to take this into consideration when com-
paring the phenotypes of mutants.
How is JMY’s actin assembly activity regulated in cells? Recent 
cell biological experiments suggest that, in vivo, JMY activity is reg-
ulated by interaction with inhibitory binding partners. One obvious 
potential regulator is the nuclear import machinery, specifically the 
importin α/β complex (Supplemental Figure S4, D and E). The in-
hibitory effect of Impβ, however, relies on direct competition with 
monomeric actin, which has a cytoplasmic concentration at least 
20-fold higher than that of Impβ (Gordon et al., 1976; Görlich et al., 
1994). It is therefore extremely unlikely that importins regulate JMY 
activity in vivo.
Of interest, JMY requires its polyproline domain for retention in 
the cytoplasm (Figure 2F and Supplemental Figure S3A). Most pro-
teins that activate the Arp2/3 complex contain a polyproline domain 
N-terminal to the WCA region (Rottner et al., 2010), and it is be-
lieved that polyproline domains facilitate the recruitment of profilin-
bound actin monomers to Arp2/3 activators (Witke, 2004). Because 
the polymerizable pool of actin monomers in cells is largely bound 
to profilin (Kaiser et al., 1999), without the polyproline sequence it is 
possible that occupancy of the WH2 domains by actin is low, making 
this mutant equivalent to PWWWCA[A*B*C*]. Thus JMY could po-
tentially be regulated by a protein that binds directly to its polypro-
line domain.
In addition to JMY and MAL, we identified 26 other actin-bind-
ing proteins with putative NLSs. It will be interesting to test whether 
any of these plays a role in actin assembly in the nucleus. Of particu-
lar interest are the 14 with overlap between ABD and NLS. Although 
most do not appear to shuttle in an actin-dependent manner, it is 
possible that their actin-regulatory activities are regulated by impor-
tin binding (and RanGTP). This could allow for control of their activi-
ties in the interphase nucleus or around mitotic chromosomes, simi-
lar to spindle factors, including the microtubule-organizing proteins 
TPX2 (Gruss et al., 2001) and NuMA (Nachury et al., 2001; Wiese 
et al., 2001), and nuclear lamins (Tsai et al., 2006). Future work will 
test the role of these proteins in coupling actin dynamics with nu-
clear and mitotic events.
MATERIALS AND METHODS
Bioinformatics
Canonical domain alignments of well-characterized ABDs, including 
monomer-binding families (WH2, RPEL) and filament-binding fami-
lies (calponin homology, formin homology 2, ILWEQ, ezrin/radixin/
moesin), were generated from published alignments supplemented 
with results of a high-stringency National Center for Biotechnology 
Information (NCBI) protein Basic Local Alignment Search Tool 
(pBLAST) search (e value, <0.00001) to ensure alignment diversity. 
Human proteins containing putative ABDs were identified using a 
low-stringency NCBI BLASTp search (e value, <0.05) based on simi-
larity to members of canonical domain alignments. ABD- and NLS-
containing candidates were identified from these results based on 
the presence of 1) one or more sequence motifs identified by NLS 
regular expression patterns from the NLSdb (http://rostlab.org/
services/nlsdb/), 2) detectable conservation within the characterized 
actin-binding sites within each ABD using BLASTp (e value, <0.00001 
for actin-binding sites >50 residues in length; any detectable similar-
ity for actin-binding sites <50 residues), and 3) <5 residues of sepa-
ration between putative NLS and ABD regions.
Molecular biology
Constructs were cloned from full-length mouse JMY or MAL using 
standard techniques. Primer sequences are available upon request. 
apoptosis. We find that this DNA damage–induced nuclear accumu-
lation requires a nuclear localization sequence in JMY buried within 
a cluster of actin monomer-binding sites. We also find that mono-
meric actin regulates JMY’s nuclear import by blocking interaction 
with the import machinery. These results argue that nuclear accumu-
lation of JMY may be triggered by DNA damage–induced actin as-
sembly. Consistent with this idea, we observed that DNA damage 
induces robust actin polymerization, nearly doubling the filamentous 
actin concentration in the cytoplasm and significantly reducing the 
concentration of monomeric actin. This observation fits with previous 
studies demonstrating DNA damage–induced actin assembly (Levee 
et al., 1996) and identifying a Rho-dependent pathway that links 
DNA damage to actin filament assembly (Croft et al., 2005, 2011).
Is it possible that JMY’s localization is dependent on binding to 
filamentous actin? We showed previously that, in vitro, JMY binds 
monomeric actin but does not appreciably copellet with filamen-
tous actin or cap filament ends (Zuchero et al., 2009). In cells JMY 
does not localize strongly to actin-rich structures such as stress fi-
bers, nor does depolymerizing actin filaments with LatB affect JMY 
localization. Together these results argue that actin filaments do not 
directly influence JMY’s subcellular localization.
The localization of both JMY and the MRTF family member MAL 
is determined by competition between actin monomers and the 
nuclear import machinery, but regulation of the two proteins is not 
identical. For example, when MAL is concentrated in the nucleus, 
treatment of cells with latrunculin B causes it to move into the cyto-
plasm (Vartiainen et al., 2007; Figure 3D), consistent with the fact 
that MAL shuttles continuously between the two compartments and 
can be trapped in the cytoplasm by association with newly liberated 
actin monomers. In contrast, latrunculin does not deplete JMY from 
nuclei of cells with damaged DNA (Supplemental Figure S3B), con-
sistent with our observation that JMY does not cycle between nu-
cleus and cytoplasm (Figure 3, A–C). Why does MAL cycle between 
nucleus and cytoplasm, whereas JMY does not? The difference 
could reflect tighter inhibition of nuclear import by the WH2–actin 
complexes of JMY than that of the RPEL–actin complexes of MAL, 
or it could reflect stable association of JMY with nuclear partners, 
perhaps components of the DNA damage response (Shikama et al., 
1999; Demonacos et al., 2001).
The lack of continuous cycling means that once JMY is in the 
nucleus its localization is insensitive to changes in cytoplasm actin. In 
this way JMY’s nuclear localization performs like a toggle switch: a 
transient dip in monomeric actin concentration produces prolonged 
nuclear accumulation. This is probably important for its cellular func-
tion. For example, JMY promotes initiation of apoptosis and, early in 
this process, the concentration gradient of Ran-GTP between the 
nucleoplasm and cytoplasm collapses, trapping many NLS-contain-
ing proteins in the cytoplasm bound to Impα/β (Wong et al., 2009). 
If JMY shuttled back and forth, it would not remain in the nucleus of 
apoptotic cells. In later stages of apoptosis the concentration of mo-
nomeric actin increases (Suarez-Huerta et al., 2000), which would 
also trap rapidly shuttling JMY molecules in the cytoplasm.
Once in the nucleus, does actin also contribute to JMY-mediated 
transcription? Coutts et al. (2009) found that JMY targeted to the 
nucleus with an NLS stimulates p53-dependent transcription of a 
reporter gene, and LatB blocks this. This suggests that the role of 
JMY in transcription either requires actin polymerization or is inhib-
ited by actin monomers. Now that actin- and Arp2/3–binding mu-
tants of JMY have been characterized, it will be interesting to test 
whether JMY promotes actin polymerization in the nucleus and 
whether it requires this for its role in activating p53. We show here 
that different actin-binding mutations can perturb the localization of 
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(Sigma-Aldrich) was used at 200 ng/ml. We made working stocks of 
all drugs or vehicle (dimethyl sulfoxide for LatB and jasp; methanol 
for LMB) in warm medium, replaced old medium with drugged me-
dium, and incubated for the given time at 37° with 5% CO2. Follow-
ing treatment, cells were washed twice with warm PBS prior to frac-
tionation or fixation for microscopy. For UV irradiation, medium was 
fully aspirated from cells, and they were subjected to a dose of 50 J/
m2 short-wave UV (0.5 mW/cm2 for 10 s) in a GS Genelinker UV 
chamber (Bio-Rad, Hercules, CA; to achieve this low fluence rate, we 
needed to remove bulbs from the UV chamber). Fresh, warm me-
dium was immediately added, and cells were returned to the incu-
bator for the indicated time before fixing for imaging.
For calculation of phalloidin intensities, U2OS cells were UV 
treated at staggered times, so that all conditions were fixed at the 
same time postplating. Cells were fixed and permeabilized as de-
scribed, stained for 15 min with 0.7 U/ml Alexa Fluor 568–phalloidin 
(Invitrogen), washed three times, and mounted as described. Four 
coverslips per condition, on two separate experimental days, were 
imaged. Ten micrographs per coverslip (>500 cells per coverslip, 
spanning the entire coverslip) were acquired blindly by focusing on 
the DAPI channel. Average cellular phalloidin intensity was mea-
sured in regions of interest containing all cells, using ImageJ. Slide 
background intensity was subtracted, and values were normalized 
by dividing by the average intensity of untreated cells.
Cellular fractionations
Approximately 1 × 106 cells were harvested, washed with ice-cold 
PBS, and resuspended in hypotonic buffer (10 mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid [HEPES], pH 7.5, 10 mM KCl, 
1.5 mM MgCl2, 0.5 dithiothreitol, 5 μg/ml aprotinin, 15 μg/ml ben-
zamidine, 10 μg/ml leupeptin, 5 μg/ml pepstatin A, 1 mM phenyl-
methanesulfonylfluoride, and 40 μg/ml soybean trypsin inhibitor). 
Cells were pelleted in a microfuge by spinning at 1000 rpm for 
5 min at 4ºC and then lysed on ice for 10 min in hypotonic buffer 
plus 0.5% NP-40. Nuclei were pelleted by spinning at 3000 rpm for 
2 min as described, and cytoplasmic fraction was aspirated and 
held on ice. Nuclei were washed with hypotonic buffer, assessed for 
quality by phase contrast microscopy, transferred to a new tube, 
and lysed in 8 M urea plus sample buffer, then boiled and sonicated 
prior to SDS–PAGE. For each fractionation experiment we blotted 
against HSP70 (cytoplasmic marker) and lamin B1 (nuclear marker) 
to monitor separation of cytoplasmic and nuclear fractions. Stan-
dard methods were used for immunoblotting, using 1:500 dilutions 
of 1289 (Coutts et al., 2007) and YA16 (Santa Cruz Biotechnology, 
Santa Cruz, CA) anti-JMY primary antibodies, mouse anti–lamin B1 
(Invitrogen), mouse anti-HSP70 (Santa Cruz Biotechnology), 1:200 
goat anti-Impβ (Santa Cruz Biotechnology), or 1:1000 mouse anti–
actin JLA20 (Calbiochem). Horseradish peroxidase–conjugated 
secondaries (Jackson ImmunoResearch Laboratories, West Grove, 
PA) were used at 1:10,000, and ECL reagent (SuperSignal West 
Pico, Pierce, Rockford, IL) was used according to the manufacturer’s 
instructions.
For quantification, subsaturated immunoblots were scanned 
(bands were deemed subsaturated if they were still translucent, i.e., 
text could be read through the band), and band intensity was mea-
sured and background subtracted in ImageJ. We measured relative 
nuclear JMY signal between jasp-treated and untreated cell lysates 
in the same blot. Measuring this ratio in several exposures of the 
same immunoblot confirmed that this ratio did not vary appreciably 
with different blot exposure intensities, provided they were subsatu-
rated. Thus we could compare several experimental replicates with-
out having to precisely match exposure intensity.
JMY mutations are as follows: A*B*C* refers to triplicate mutations 
in each WH2 to block actin binding, in WH2-a (LF857AA, L870A), 
WH2-b (VL889AA, L900A), and WH2-c (IL920AA, L930A). Amino 
acid numbers of JMY constructs are as follows: GFP-PWWWCA, 
791–983; GFP-PWWW, 791–938; GFP-WWW, 853–938; GFP-
JMYΔCA, 1–938; GFP-JMYΔWWWCA, 1–852. MAL constructs are 
as follows: full-length MAL-GFP, 1–1021; RPEL-GFP, 2–261. The 
numbering of mouse MAL begins at leucine −92 (Miralles et al., 
2003). All constructs were sequenced to ensure no mutations were 
introduced during cloning. We used pEGFP-C1 and pEGFP-N3 
(Clontech, Mountain View, CA) as host vectors for making enhanced 
GFP fusions.
Cell culture
HeLa and U2OS cells (American Type Culture Collection, Manassas, 
VA) were cultured in DMEM supplemented with 10% fetal bovine 
serum, 2 mM l-glutamine, nonessential amino acids, and penicillin–
streptomycin (University of California, San Francisco, Cell Culture 
Facility, San Francisco, CA) at 37°C with 5% CO2. For transfection, 
cells were seeded onto glass coverslips overnight and transfected 
with GFP constructs using Lipofectamine LTX (Invitrogen, Carlsbad, 
CA), according to the manufacturer’s protocol. For Impβ1 RNAi, 
GFP-JMY stable cells (Zuchero et al., 2009) were transfected with 
100 nM nontargeting (Stealth Medium GC#2; Invitrogen) or Impβ1 
siRNA (targeting bases 497–521 of human Impβ mRNA; Miki et al., 
2008; purchased from Invitrogen), using Lipofectamine 2000 ac-
cording to manufacturer’s protocols, and grown for 3 d prior to UV 
treatment. Alternatively, siRNA and plasmid DNA were cotrans-
fected using Lipofectamine 2000. For immunofluorescence, cells 
were fixed for 30 min in 3.2% formaldehyde in phosphate-buffered 
saline (PBS). Cells were then permeabilized with 0.1% Triton-X-100 
in PBS, and nuclei were stained with 0.5 μg/ml 4′,6-diamidino-2-
phenylindole (DAPI; Sigma-Aldrich, St. Louis, MO). Fixed samples 
were mounted with fluorescent mounting medium (DakoCytoma-
tion, Hamburg, Germany).
Microscopy
Epifluorescence and wide-field images were acquired on a TE300 
inverted microscope (Nikon, Melville, NY) equipped with a Hama-
matsu C4742-98 cooled charge-coupled device camera (Hama-
matsu, Hamamatsu, Japan), using 100× and 60×, 1.4 numerical ap-
erture, Plan Apo objectives (Nikon) with MicroManager software 
(Stuurman et al., 2007). We used ImageJ (National Institutes of 
Health, Bethesda, MD) and Adobe Photoshop (Adobe, San Jose, 
CA) for image analysis and contrast adjustment. For live-cell imag-
ing, cells were transfected, split onto glass coverslips after 18–24 h, 
and then given fresh medium with drugs or vehicle and kept at 37°C 
during image acquisition. Stable lines of U2OS cells expressing 
GFP-JMY were described previously (Zuchero et al., 2009). Localiza-
tion of GFP fusion proteins was scored as predominantly cytoplas-
mic, equally distributed between the cytoplasm and nucleus (C/N), 
or predominantly cytoplasmic by an observer blind to the experi-
mental condition (Guettler et al., 2008). Percentages presented in 
the text refer to percentage of cells in each category, unless other-
wise indicated.
Drug treatments and uV irradiation
Jasplakinolide (Calbiochem, La Jolla, CA) and latrunculin B (Biomol 
International, Enzo Life Sciences, Plymouth, PA) were used at 
500 nM in medium, and treatments were for 30 min. Leptomycin B 
(Sigma-Aldrich) was used at 20 nM for 30 min or 16 h, as noted. 
Etoposide (Sigma-Aldrich) was used at 10 μM, and neocarzinostatin 
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CT-JMY (amino acids 583–983, encompassing both NLS sequences) 
and 5 μM Impβ or an equivalent volume of Impβ storage buffer. For 
half-time calculations, reactions were normalized by zeroing traces, 
dividing by the plateau value, and solving for time at half-maximal 
fluorescence (0.5 a.u.). All error values are SEM. We used two-tailed 
unpaired t tests, assuming unequal variance, to calculate p values 
(Excel; Microsoft, Redmond, WA).
Biochemistry
JMY and MAL fragments were expressed as GST fusions in Escheri-
chia coli and purified using a combination of glutathione and cation 
chromatography. For actin polymerization experiments the GST was 
removed to prevent dimerization of the recombinant protein. We 
used JMY(C978S) for biochemistry to improve reproducibility 
(Zuchero et al., 2009). Recombinant NusA-hexahistidine–tagged 
Impβ was purified by cobalt chromatography, removal of the NusA 
tag by cleavage with trypsin, and gel filtration on a Superdex 200 
column. Protein concentrations were calculated using predicted 
molar extinction coefficients for JMY peptides (ProtParam, http://
web.expasy.org/protparam/) or by quantitative SDS–PAGE with 
SYPRO Red staining (Invitrogen).
For GST pulldowns, 10 μM GST-tagged proteins or GST alone 
was bound to glutathione–Sepharose 4B (GE Healthcare, Piscat-
away, NJ) or glutathione magnetic beads (Pierce) in PBS, 0.5 μM 
TCEP, and 20% glycerol, with rotation, for 2–16 h at 4º, then washed 
three times to remove unbound protein. Note that background 
binding of proteins to glutathione magnetic beads (GST-MAL ex-
periments) is much reduced compared with glutathione–Sepharose 
beads (GST-JMY experiments). Loaded beads (GST fusion proteins 
at ∼1 μM in final reaction volume) were rotated with proteins or pro-
tein storage buffer in PBS, 0.5 μM tris(2-carboxyethyl)phosphine 
(TCEP), and 5 mg/mL bovine serum albumin (carrier) for 2–3 h at 
4°C. As noted, 2.5 μM each Impα and Impβ was used. Actin was 
kept monomeric by using 2× molar equivalent of LatB. Beads were 
pelleted by centrifugation or magnetic separation, supernatant re-
moved, and washed three times with PBS + 0.01% NP-40, transfer-
ring to a new tube in the final wash to prevent eluting protein non-
specifically adsorbed to the tube wall. Bound proteins were 
recovered in sample buffer (same volume as reactions), and samples 
were analyzed by SDS–PAGE (NuPage gradient gels; GE Health-
care) with SYPRO Red staining and quantified by using a multifor-
mat imager (Typhoon 9400; GE Healthcare) and ImageQuant soft-
ware (GE Healthcare). SYPRO Red binds to SDS, and thus the 
measured fluorescence reflects mass of protein; we divided values 
by the molecular weight of the protein (42,000 Da for actin, 97,000 
Da for Impβ, and 60,000 Da for Impα) to calculate bound protein in 
relative molar terms. For visualization of Alexa 488–labeled actin, 
gels were scanned (Typhoon 9400) prior to SYPRO Red staining.
Actin polymerization assays
Actin was purified from Acanthamoeba castellanii as described 
(Gordon et al., 1976), labeled with pyrene iodoacetamide or Alexa 
488 C5 maleimide as described (Cooper et al., 1983; Akin and 
Mullins, 2008), stored in buffer A (0.2 mM ATP, 0.5 mM TCEP, 
0.1 mM CaCl2, 0.02% wt/vol sodium azide, 2 mM Tris, pH 8.0, at 
4°C), and gel filtered before use. Acanthamoeba actin is 95.5% 
identical, 99.2% conserved with regard to human β-actin (compared 
with human or rabbit skeletal muscle actin, 92.8% identical), and so 
represents a better model of cytoplasmic actin than skeletal muscle 
actin. Arp2/3 was purified from Acanthamoeba as described (Dayel 
et al., 2001) and flash frozen with 10% glycerol. Actin polymerization 
assays were performed as described (Zuchero et al., 2009) in 1× 
KMEH (50 mM KCl, 1 mM MgCl2, 1 mM ethylene glycol tetraacetic 
acid [EGTA], 10 mM HEPES, pH 7.0). Ca2+-actin was converted into 
Mg2+-actin by incubation of actin in ME (50 mM MgCl2, 0.2 mM 
EGTA) for 2 min prior to adding 10× KMEH and test components. 
Pyrene fluorescence was measured with a Synergy 4 plate reader 
and Gen5 software (BioTek, Winooski, VT). Unless otherwise noted, 
polymerization reactions contained 4 μM actin (5% pyrene labeled) 
and 250 nM JMY. Importin competition reactions contained 200 nM 
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